FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4252443575> ?p ?o ?g. }

• W4252443575 abstract "<sec> <title>BACKGROUND</title> Oral antineoplastic agents (OAAs) have revolutionized cancer management. However, they have been reported with adverse side effects and drug-drug interactions. Moreover, patient adherence to OAA treatment is critical. Mobile apps can enable remote and real-time pharmacotherapeutic monitoring of patients, while also promoting patient autonomy in their health care. </sec> <sec> <title>OBJECTIVE</title> The primary objective was to analyze the effect of using a mobile app for the follow-up of patients with oncohematological malignancies undergoing treatment with OAAs on their health outcomes. The secondary objectives were to analyze the role of the app in communication with health care professionals and patient satisfaction with the app. </sec> <sec> <title>METHODS</title> We performed a comparative, quasi-experimental study based on a prepost intervention with 101 patients (control group, n=51, traditional pharmacotherapeutic follow-up vs intervention group, n=50, follow-up through e-OncoSalud, a custom-designed app that promotes follow-up at home and the safety of patients receiving OAAs). The effect of this app on drug safety, adherence to treatment, and quality of life was evaluated. </sec> <sec> <title>RESULTS</title> With regard to drug safety, 73% (37/51) of the patients in the control group and 70% (35/50) of the patients in the intervention group (<i>P</i>=.01) presented with drug-related problems. The probability of detecting an insufficiently treated health problem in the intervention group was significantly higher than that in the control group (<i>P</i>=.04). The proportion of patients who presented with side effects in the intervention group was significantly lower than that in the control group (<i>P</i>&gt;.99). In the control group, 49% (25/51) of the patients consumed some health resources during the first 6 months of treatment compared with 36% (18/50) of the patients in the intervention group (<i>P</i>=.76). Adherence to treatment was 97.6% (SD 7.9) in the intervention group, which was significantly higher than that in the control group (92.9% [SD 10.0]; <i>P</i>=.02). The EuroQol-5D in the intervention group yielded a mean (SD) index of 0.875 (0.156), which was significantly higher than that in the control group (0.741 [0.177]; <i>P</i>&lt;.001). Approximately 60% (29/50) of the patients used the messaging module to communicate with pharmacists. The most frequent types of messages were acknowledgments (77/283, 27.2%), doubts about contraindications and interactions with OAAs (70/283, 24.7%), and consultations for adverse reactions to treatment (39/283, 13.8%). The satisfaction with the app survey conducted in the intervention group yielded an overall mean (SD) score of 9.1 (0.4) out of 10. </sec> <sec> <title>CONCLUSIONS</title> Use of e-OncoSalud for the real-time follow-up of patients receiving OAAs facilitated the optimization of some health outcomes. The intervention group had significantly higher health-related quality of life and adherence to treatment than the control group. Further, the probability of the intervention group presenting with side effects was significantly lower than that of the control group. </sec>" @default.
• W4252443575 created "2022-05-12" @default.
• W4252443575 creator A5020567651 @default.
• W4252443575 creator A5036747390 @default.
• W4252443575 creator A5039336332 @default.
• W4252443575 creator A5048803850 @default.
• W4252443575 creator A5051724538 @default.
• W4252443575 creator A5064449764 @default.
• W4252443575 creator A5068965297 @default.
• W4252443575 creator A5078047464 @default.
• W4252443575 creator A5082744602 @default.
• W4252443575 date "2020-05-20" @default.
• W4252443575 modified "2023-09-27" @default.
• W4252443575 title "Effect of a Mobile App for the Pharmacotherapeutic Follow-Up of Patients With Cancer on Their Health Outcomes: Quasi-Experimental Study (Preprint)" @default.
• W4252443575 cites W2164995937 @default.
• W4252443575 doi "https://doi.org/10.2196/preprints.20480" @default.
• W4252443575 hasPublicationYear "2020" @default.
• W4252443575 type Work @default.
• W4252443575 citedByCount "0" @default.
• W4252443575 crossrefType "posted-content" @default.
• W4252443575 hasAuthorship W4252443575A5020567651 @default.
• W4252443575 hasAuthorship W4252443575A5036747390 @default.
• W4252443575 hasAuthorship W4252443575A5039336332 @default.
• W4252443575 hasAuthorship W4252443575A5048803850 @default.
• W4252443575 hasAuthorship W4252443575A5051724538 @default.
• W4252443575 hasAuthorship W4252443575A5064449764 @default.
• W4252443575 hasAuthorship W4252443575A5068965297 @default.
• W4252443575 hasAuthorship W4252443575A5078047464 @default.
• W4252443575 hasAuthorship W4252443575A5082744602 @default.
• W4252443575 hasBestOaLocation W42524435752 @default.
• W4252443575 hasConcept C121608353 @default.
• W4252443575 hasConcept C126322002 @default.
• W4252443575 hasConcept C159110408 @default.
• W4252443575 hasConcept C160735492 @default.
• W4252443575 hasConcept C162324750 @default.
• W4252443575 hasConcept C197934379 @default.
• W4252443575 hasConcept C2779951463 @default.
• W4252443575 hasConcept C2780665704 @default.
• W4252443575 hasConcept C50522688 @default.
• W4252443575 hasConcept C512399662 @default.
• W4252443575 hasConcept C71924100 @default.
• W4252443575 hasConcept C98274493 @default.
• W4252443575 hasConceptScore W4252443575C121608353 @default.
• W4252443575 hasConceptScore W4252443575C126322002 @default.
• W4252443575 hasConceptScore W4252443575C159110408 @default.
• W4252443575 hasConceptScore W4252443575C160735492 @default.
• W4252443575 hasConceptScore W4252443575C162324750 @default.
• W4252443575 hasConceptScore W4252443575C197934379 @default.
• W4252443575 hasConceptScore W4252443575C2779951463 @default.
• W4252443575 hasConceptScore W4252443575C2780665704 @default.
• W4252443575 hasConceptScore W4252443575C50522688 @default.
• W4252443575 hasConceptScore W4252443575C512399662 @default.
• W4252443575 hasConceptScore W4252443575C71924100 @default.
• W4252443575 hasConceptScore W4252443575C98274493 @default.
• W4252443575 hasLocation W42524435751 @default.
• W4252443575 hasLocation W42524435752 @default.
• W4252443575 hasOpenAccess W4252443575 @default.
• W4252443575 hasPrimaryLocation W42524435751 @default.
• W4252443575 hasRelatedWork W13209649 @default.
• W4252443575 hasRelatedWork W18663925 @default.
• W4252443575 hasRelatedWork W21368663 @default.
• W4252443575 hasRelatedWork W21556513 @default.
• W4252443575 hasRelatedWork W2254145305 @default.
• W4252443575 hasRelatedWork W5861673 @default.
• W4252443575 hasRelatedWork W6368067 @default.
• W4252443575 hasRelatedWork W7567564 @default.
• W4252443575 hasRelatedWork W8568283 @default.
• W4252443575 hasRelatedWork W3058889 @default.
• W4252443575 isParatext "false" @default.
• W4252443575 isRetracted "false" @default.
• W4252443575 workType "article" @default.